Genovate Biotechnology Co., Ltd. (TPEX:4130)
Taiwan · Delayed Price · Currency is TWD 32.40
-0.80 (-2.41%)
Mar 4, 2026, 9:20 AM CST
Genovate Biotechnology Market Cap
Genovate Biotechnology has a market cap or net worth of 3.78 billion as of March 3, 2026. Its market cap has increased by 45.66% in one year.
Market Cap
3.78B
Enterprise Value
3.30B
Revenue
492.41M
Ranking
n/a
PE Ratio
323.28
Stock Price
32.40
Market Cap Chart
Since November 3, 2008, Genovate Biotechnology's market cap has increased from 664.80M to 3.78B, an increase of 468.07%. That is a compound annual growth rate of 10.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 3.62B | 14.80% |
| Dec 31, 2025 | 3.15B | 35.56% |
| Dec 31, 2024 | 2.32B | -20.11% |
| Dec 29, 2023 | 2.91B | -17.02% |
| Dec 30, 2022 | 3.51B | 31.05% |
| Dec 30, 2021 | 2.68B | -15.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medigen Biotechnology | 4.21B |
| Formosa Pharmaceuticals | 4.20B |
| Intech Biopharm | 4.08B |
| ACRO Biomedical | 3.89B |
| BRIM Biotechnology | 3.62B |
| Sagittarius Life Science | 3.50B |
| Shine-On BioMedical | 3.34B |
| Syngen Biotech | 3.25B |